Skip to main content

Table 2 Occurrence of epilepsy in people admitted with multiple sclerosis, and of multiple sclerosis in people admitted with epilepsy: observed (O) and expected number (E) of cases in each cohort, relative risk (RR) a in the exposure cohort compared with the control cohort b , with its 95% confidence intervals (95% CI), and p values, by time intervals between the two conditions

From: Association between multiple sclerosis and epilepsy: large population-based record-linkage studies

Exposure cohort

Time interval

Outcome

ORLS (1963–1998)

England (1999–2011)

O

E

RR (95% CI)

pvalue

O

E

RR (95% CI)

pvalue

Multiple sclerosis

<1 year

Epilepsy

13

3.6

3.6 (1.92–6.23)

<0.001

574

370.0

1.6 (1.44–1.70)

<0.001

1–4 years

16

4.3

3.7 (2.12–6.08)

<0.001

1194

251.0

4.9 (4.66–5.24)

<0.001

5–9 years

14

3.2

4.4 (2.41–7.48)

<0.001

726

166.0

4.5 (4.20–4.88)

<0.001

10+ years

19

4.1

4.7 (2.80–7.34)

<0.001

86

22.8

3.9 (3.11–4.85)

<0.001

Total

62

15.3

4.1 (3.14–5.27)

<0.001

2580

809.7

3.3 (3.14–3.40)

<0.001

Epilepsy

<1 year

Multiple sclerosis

9

3.3

2.9 (1.29–5.67)

0.003

206

196.1

1.1 (0.91–1.21)

0.48

1–4 years

9

3.4

2.7 (1.21–5.23)

0.006

394

154.0

2.8 (2.52–3.13)

<0.001

5–9 years

6

2.7

2.3 (0.82–5.09)

0.083

206

90.5

2.4 (2.10–2.83)

<0.001

10+ years

9

4.2

2.2 (0.99–4.24)

0.034

19

9.9

2.0 (1.19–3.27)

<0.005

 

Total

 

33

13.6

2.5 (1.71–3.54)

0.001

825

450.4

1.9 (1.79–2.07)

<0.001

  1. aAll analyses were undertaken initially within five-year age groups (and within the other strata used), using the combined MS and control cohorts (or the combined epilepsy and control cohorts) as the ‘standard’, to provide observed and expected numbers within (1) the MS cohort (or epilepsy cohort) and (2) the control cohort, within each stratum group. The stratum-specific observed and expected numbers in each cohort were then summed to give an age-standardised all-ages total, adjusted for age in 5-year bands, time period in single calendar years, region of residence and deprivation score associated with patients’ area of residence, in quintiles.
  2. bConditions used in control cohort, with Office of Population, Censuses and Surveys (OPCS) code edition 4 for operations and ICD10 code for diagnosis (with equivalent codes used for other coding editions): adenoidectomy (OPCS4 E20), tonsillectomy (F34, F36), appendectomy (H01–H03), dilation and curettage (Q10–Q11), hip replacement (W37–W39), knee replacement (W40–W42), squint (ICD10 H49–H51), cataract (H25), otitis (H60–H67), varicose veins (I83), haemorrhoids (I84), upper respiratory tract infections (J00–J06), deflected septum, nasal polyp (J33+J34.2), impacted tooth and other disorders of teeth (K00–K03), inguinal hernia (K40), in-growing nail, toenail and other diseases of nail (L60), bunion (M20.1), internal derangement of knee (M23), contraceptive management (Z30).